Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.406, 2003-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 308, 2001-01 ,pp. :
Access to resources
Recommend
IBS lowers QOL, increases costs in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 371, 2002-01 ,pp. :
Tegaserod improves QOL, cost effective in IBS
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :
Meaningful QOL gains with alosetron in women with IBS-D
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. :
Tegaserod improves QOL, cost effective in IBS
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 468, 2004-01 ,pp. :